Skip to main content

Table 4 Patient-reported outcome measures relative to chemoprophylaxis use

From: Short-duration chemoprophylaxis might reduce incidence of deep vein thrombosis in Asian patients undergoing total knee arthroplasty

   Patients given chemoprophylaxis (median) Patients not given chemoprophylaxis (median) p value
Pre-op SF36v2 PCS 30.45 30.09 0.312
SF36v2 MCS 58.68 58.60 0.171
WOMAC 67.20 65.20 0.222
KSS Function 50.00 50.00 0.249
KSS Knee 41.50 36.00 0.054
Post-op 6 months SF36v2 PCS 48.53 47.94 0.857
SF36v2 MCS 58.60 58.50 0.403
WOMAC 91.70 90.63 0.537
KSS Function 80.00 70.00 0.325
KSS Knee 94.00 94.00 0.687
Post-op 24 months SF36v2 PCS 48.00 49.37 0.391
SF36v2 MCS 59.00 58.83 0.352
WOMAC 90.91 92.97 0.218
KSS Function 80.00 80.00 0.189
KSS Knee 95.00 97.00 0.979
  1. SF36v2 PCS Short Form 36 Version 2 – Physical Component Summary, SF36v2 MCS Short Form 36 Version 2 – Physical Component Summary, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, KSS Function Knee Society Score – Function Score, KSS Knee Knee Society Score – Knee Score